Acrivon Therapeutics
ACRV
#8030
Rank
A$0.33 B
Marketcap
$10.72
Share price
0.30%
Change (1 day)
46.11%
Change (1 year)

Earnings for Acrivon Therapeutics (ACRV)

Earnings in 2024 (TTM): -A$0.13 Billion

According to Acrivon Therapeutics's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -A$0.11 Billion a decrease over its 2022 earnings that were of -A$52.18 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Acrivon Therapeutics from 2022 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -A$0.13 Billion17.88%
2023 -A$0.11 Billion105.48%
2022 -A$52.18 Million